Global state: relapse ‐ medium term ‐ not measured · patients with schizophrenia
BRIEF FAMILY INTERVENTION showed no clear difference in global state ‐ relapse ‐ medium to long term relapse rates (clinical… compared with STANDARD CARE (low certainty).
1 finding from 1 review
Compliance with medication · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life/satisfaction with care ‐ for recipients or carers ‐ medium to long term ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Family outcome ‐ understanding schizophrenia, average endpoint score Patient Rejection Scale (PRS ‐ high score = greater acceptance). Scale from: 24 to 168. · patients with schizophrenia
1 finding from 1 review
Economic outcomes ‐ costs of care ‐ long term ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Compliance Measured using: loss to · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Mental state: any outcome · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Cognitive function · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Functioning: 2. Social ‐ average change in social problem solving Measured using: SPSI‐R · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Quality of life: any outcome · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Satisfaction with treatment: Average change score ‐ interest in social skills training Measured using: un‐referenced measure · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Acceptability (of intervention): Leaving the studies early – any reason Loss to · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Compliance with medication · patients with treatment compliance for people with serious mental illness
INFORMATION AND COMMUNICATION TECHNOLOGY (ICT) FOR PROMPTING/SUPPORT… showed no clear difference in compliance with medication: Would stop taking medication Morisky… compared with STANDARD CARE (moderate certainty).
1 finding from 1 review
Service Use: Not reported · patients with treatment compliance for people with serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects/events · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Change in depressive symptoms · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Acceptability (of intervention): Leaving the studies early – any reason Loss to · patients with treatment compliance for people with serious mental illness
INFORMATION AND COMMUNICATION TECHNOLOGY (ICT) FOR PROMPTING/SUPPORT… showed no clear difference in acceptability (of intervention): Leaving the studies early – any… compared with STANDARD CARE (low certainty).
1 finding from 1 review
Average change in quality of life/satisfaction · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Costs · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Global state ‐ clinical improvement ‐ medium term As defined by each study · patients with schizophrenia
TRIFLUOPERAZINE may leads to higher global state ‐ clinical improvement ‐ medium term As defined by each… compared with PLACEBO (low certainty).
1 finding from 1 review